Valuation OneSource Specialty Pharma Limited
Stocks
ONESOURCE
INE013P01021
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,749.70 INR | +1.06% |
|
+5.97% | -3.36% |
Company Valuation: OneSource Specialty Pharma Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 200,521 | 200,596 | - | - |
| Change | - | 0.04% | - | - |
| Enterprise Value (EV) 1 | 200,521 | 180,604 | 209,452 | 201,760 |
| Change | - | -9.93% | -0.92% | -3.67% |
| P/E | -1,075x | -229x | 43.2x | 20.9x |
| PBR | - | 3.45x | 3.2x | 2.82x |
| PEG | - | -1x | -0x | 0x |
| Capitalization / Revenue | - | 11.9x | 9.2x | 5.9x |
| EV / Revenue | - | 12.7x | 9.61x | 5.93x |
| EV / EBITDA | - | 59.4x | 26.6x | 14.7x |
| EV / EBIT | - | 719x | 37.9x | 19.5x |
| EV / FCF | - | -32.2x | 37.9x | 30.9x |
| FCF Yield | - | -3.1% | 2.64% | 3.23% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -1.63 | -6.44 | 40.5 | 83.73 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | 14,216 | 21,798 | 34,019 |
| EBITDA 1 | - | 3,042 | 7,875 | 13,689 |
| EBIT 1 | - | 251.3 | 5,526 | 10,322 |
| Net income 1 | -179.7 | -738 | 4,459 | 8,968 |
| Net Debt 1 | - | 11,733 | 8,856 | 1,164 |
| Reference price 2 | 1,752.25 | 1,749.70 | 1,749.70 | 1,749.70 |
| Nbr of stocks (in thousands) | 114,436 | 114,646 | - | - |
| Announcement Date | 5/5/25 | 5/13/26 | - | - |
1INR in Million2INR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -176.06x | 15.6x | 75.3x | - | 2.08B | |
| 32.72x | 5.89x | 17.49x | 0.98% | 47.88B | |
| -22.95x | 343.53x | -20.98x | -.--% | 39.09B | |
| 49x | 5.01x | 32.38x | -.--% | 36.75B | |
| 31.16x | 3.12x | 13.46x | -.--% | 40.55B | |
| 27.11x | 7.84x | 19.63x | 0.43% | 27.96B | |
| 32.47x | 5.31x | 24.11x | -.--% | 15.94B | |
| 22.79x | 2x | 8.65x | 1.16% | 13.55B | |
| 25.48x | 2.01x | 12.17x | -.--% | 13.81B | |
| Average | 2.41x | 43.37x | 20.24x | 0.32% | 26.4B | |
| Weighted average by Cap. | 22.32x | 60.65x | 13.16x | 0.32% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONESOURCE Stock
- Valuation OneSource Specialty Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
